Measuring exercise capacity and fitness using a new non-invasive method
Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitness
This study is testing a new, easy way to measure heart and fitness levels in healthy people using a smartphone, to see if it works as well as traditional methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Precordior Ltd Industry-sponsored |
| Locations | 1 site (Turku) |
| Trial ID | NCT05936827 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate a novel non-invasive cardiac measurement technique called gyrocardiography (GCG) to assess cardiorespiratory fitness (CRF) in healthy individuals. Participants, including both athletes and non-athletic individuals, will undergo ergometry and spiroergometry to measure various hemodynamic parameters such as heart rate, cardiac strength, and VO2max. The goal is to develop a solution that can be utilized via commercially available smartphones without the need for additional equipment or specialized knowledge. The study will also include follow-up visits to monitor changes in physical activity habits.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18-65 who do not have diagnosed cardiovascular diseases and are willing to participate in follow-up visits.
Not a fit: Patients with significant cardiovascular conditions or those on medications affecting heart rate may not benefit from this study.
Why it matters
Potential benefit: If successful, this method could provide a convenient and accessible way for individuals to monitor their exercise capacity and overall fitness.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in using non-invasive methods for fitness assessment, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 18-65 years * No diagnosed cardiovascular diseases (mild hypertension or hypercholesterolemia are still allowed) * No medication affecting heart rate (i.e. Beta blocker) * Signed informed consent Follow-up visit: * Belong to non-athletic group * Intention to change physical activity habits * Willing to participate to the follow-up visit Exclusion Criteria: * Not meeting inclusion criteria * Declined to participate * Resting RR before the ergometry \> 180/110mmHg
Where this trial is running
Turku
- Paavo Nurmi Center — Turku, Finland (Recruiting)
Study contacts
- Principal investigator: Olli Heinonen, PhD — Paavo Nurmi Center
- Study coordinator: Kristiina RESEARCH & QUALITY DIRECTOR, PhD
- Email: kristiina.santalahti@precordior.com
- Phone: 0445950891
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.